Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394:407–18.

Article  PubMed  Google Scholar 

Papi A, Brightling C, Pedersen SE, et al. Asthma Lancet. 2018;391:783–800.

Article  PubMed  Google Scholar 

Pelaia C, Crimi C, Vatrella A, et al. Molecular targets for biological therapies of severe asthma. Front Immunol. 2020;11:603312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ricciardolo FLM, Guida G, Bertolini F, et al. Phenotype overlap in the natural history of asthma. Eur Respir Rev. 2023;32:220201.

Article  PubMed  PubMed Central  Google Scholar 

Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(6):1469–85.

Article  CAS  PubMed  Google Scholar 

Chung KF. Type-2-low severe asthma endotypes for new treatments: the new asthma frontier. Curr Opin Allergy Clin Immunol. 2023;23:199–204.

Article  CAS  PubMed  Google Scholar 

Humbert M, Bousquet J, Bachert C, et al. IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy. J Allergy Clin Immunol Pract. 2019;7:1418–29.

Article  PubMed  Google Scholar 

Cai T, Qiu J, Ji Y, et al. IL-17-producing ST2+group 2 innate lymphoid cells play a pathogenic role in lung inflammation. J Allergy Clin Immunol. 2019;143:229–44.

Article  CAS  PubMed  Google Scholar 

Seehus CR, Kadavallore A, de la Torre B, et al. Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nat Commun. 2017;8:1900.

Article  PubMed  PubMed Central  Google Scholar 

Sharma A, Laxman B, Naureckas ET, et al. Associations between fungal and bacterial microbiota of airways and asthma endotypes. J Allergy Clin Immunol. 2019;144:1214–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Durack J, Lynch SV, Nariya S, et al. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J Allergy Clin Immunol. 2017;140:63–75.

Article  CAS  PubMed  Google Scholar 

Nikonova A, Shilovskiy I, Galitskaya M, et al. Respiratory syncytial virus upregulates IL-33 expression in mouse model of virus-induced inflammation exacerbation in OVA-sensitized mice and in asthmatic subjects. Cytokine. 2021;138:155349.

Article  CAS  PubMed  Google Scholar 

Ravanetti L, Dijkhuis A, Dekker T, et al. IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity. J Allergy Clin Immunol. 2019;143:1355–70.

Article  CAS  PubMed  Google Scholar 

Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190:1373–82.

Article  PubMed  PubMed Central  Google Scholar 

Stier MT, Goleniewska K, Cephus JY, et al. STAT1 represses cytokine-producing Group 2 and Group 3 innate lymphoid cells during viral infection. J Immunol. 2017;199:510–9.

Article  CAS  PubMed  Google Scholar 

Hoffmann JP, Kolls JK, McCombs JE. Regulation and function of ILC3s in Pulmonary infections. Front Immunol. 2021;12:672523.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Norlander AE, Peebles RS Jr. Innate type 2 responses to respiratory syncytial virus infection. Viruses. 2020;12:521.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teo SM, Tang H, Mok D, et al. Airway Microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease. Cell Host Microbe. 2018;24:341–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez FD. Childhood asthma inception and progression: role of microbial exposures, susceptibility to viruses and early allergic sensitization. Immunol Allergy Clin North Am. 2019;39:141–50.

Article  PubMed  PubMed Central  Google Scholar 

Li C, Du X, Huang Q, et al. Repeated exposure to inactivated Streptococcus pneumoniae induces asthma-like pathological changes in mice in the presence of IL-33. Cell Immunol. 2021;369:104438.

Article  CAS  PubMed  Google Scholar 

Li Y, Chen S, Chi Y, et al. Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16. Cell Mol Immunol. 2019;16:75–86.

Article  PubMed  Google Scholar 

Helou DG, Shafiei-Jahani P, Lo R, et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat Commun. 2020;11:3998.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu YH, Lai AC, Chi PY, et al. Pulmonary IL-33 orchestrates innate immune cells to mediate respiratory syncytial virus-evoked airway hyperreactivity and eosinophilia. Allergy. 2020;75:818–30.

Article  CAS  PubMed  Google Scholar 

Helou DG, Shafiei-Jahani P, Hurrell BP, et al. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity. J Allergy Clin Immunol. 2022;149:223–36.

Article  CAS  PubMed  Google Scholar 

Nagashima H, Mahlakõiv T, Shih HY, et al. Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation. Immunity. 2019;51:682–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flamar AL, Klose C, Moeller JB, et al. Interleukin-33 induces the enzyme tryptophan hydroxylase 1 to promote inflammatory group 2 innate lymphoid cell-mediated immunity. Immunity. 2020;52:606–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wallrapp A, Riesenfeld SJ, Burkett PR, et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature. 2017;549:351–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Kasmani MY, Zheng S, et al. BATF promotes group 2 innate lymphoid cell-mediated lung tissue protection during acute respiratory virus infection. Sci Immunol. 2022;7:c9934.

Article  Google Scholar 

Xu H, Ding J, Porter C, et al. Transcriptional atlas of intestinal immune cells reveals that neuropeptide α-CGRP modulates group 2 innate lymphoid cell responses. Immunity. 2019;51:696–708.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakatani-Kusakabe M, Yasuda K, Tomura M, et al. Monitoring cellular movement with photo convertible fluorescent protein and single-cell RNA sequencing reveals cutaneous group 2 innate lymphoid cell subtypes, circulating ILC2 and skin-resident ILC2. JID Innov. 2021;1:100035.

Article  PubMed  PubMed Central  Google Scholar 

Hardman CS, Chen YL, Salimi M, et al. IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent. Sci Immunol. 2021;6:eabe5084.